G M Marshall
Overview
Explore the profile of G M Marshall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1087
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jessop S, Fuentos-Bolanos N, Mayoh C, Dolman M, Tax G, Wong-Erasmus M, et al.
Cancer Rep (Hoboken)
. 2024 Apr;
7(4):e2061.
PMID: 38662349
Background: Despite advances in therapeutics for adverse-risk acute myeloid leukaemia (AML), overall survival remains poor, especially in refractory disease. Comprehensive tumour profiling and pre-clinical drug testing can identify effective personalised...
2.
Mateos M, Trahair T, Mayoh C, Barbaro P, Sutton R, Revesz T, et al.
Thromb Res
. 2019 Apr;
178:132-138.
PMID: 31030032
Background: Symptomatic venous thromboembolism (VTE) is an unpredictable and life-threatening toxicity, which occurs early in childhood acute lymphoblastic leukemia (ALL) therapy. Approximately 5% of children will experience VTE which is...
3.
Wakefield C, Doolan E, Fardell J, Signorelli C, Quinn V, Tucker K, et al.
EBioMedicine
. 2018 Nov;
37:205-213.
PMID: 30385234
Background: Using patient-derived xenografts (PDXs) to assess chemosensitivity to anti-cancer agents in real-time may improve cancer care by enabling individualized clinical decision-making. However, it is unknown whether this new approach...
4.
Vetsch J, Wakefield C, Robertson E, Trahair T, Mateos M, Grootenhuis M, et al.
Qual Life Res
. 2018 Jan;
27(6):1431-1443.
PMID: 29372438
Purpose: Acute lymphoblastic leukemia (ALL) survivors are the largest group of childhood cancer survivors; however, their risk for late effects is high. Cancer-related late effects have the potential to compromise...
5.
Lum A, Wakefield C, Donnan B, Burns M, Fardell J, Marshall G
Child Care Health Dev
. 2017 May;
43(5):645-662.
PMID: 28543609
Background: Serious chronic illness can have a detrimental effect on school attendance, participation and engagement, leaving affected students at risk of failing to meet their developmental potential. An improved understanding...
6.
Fardell J, Vetsch J, Trahair T, Mateos M, Grootenhuis M, Touyz L, et al.
Pediatr Blood Cancer
. 2017 Mar;
64(9).
PMID: 28266135
Children with acute lymphoblastic leukemia (ALL) undergo intense anticancer treatment. We systematically reviewed 22 studies evaluating 2,073 ALL patients' health-related quality of life (HRQL) and its clinical/demographic correlates during treatment....
7.
Samuels A, Beesley A, Yadav B, Papa R, Sutton R, Anderson D, et al.
Blood Cancer J
. 2014 Aug;
4:e232.
PMID: 25083816
Relapse and acquired drug resistance in T-cell acute lymphoblastic leukemia (T-ALL) remains a significant clinical problem. This study was designed to establish a preclinical model of resistance to induction therapy...
8.
Sun Y, Liu P, Scarlett C, Malyukova A, Liu B, Marshall G, et al.
Oncogene
. 2013 Jul;
33(23):2987-94.
PMID: 23812427
The N-Myc oncoprotein induces neuroblastoma, which arises from undifferentiated neuroblasts in the sympathetic nervous system, by modulating gene and protein expression and consequently causing cell differentiation block and cell proliferation....
9.
Marshall G, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman H, van der Velden V, et al.
Leukemia
. 2013 Feb;
27(7):1497-503.
PMID: 23407458
Children with acute lymphoblastic leukemia (ALL) and high minimal residual disease (MRD) levels after initial chemotherapy have a poor clinical outcome. In this prospective, single arm, Phase 2 trial, 111...
10.
Malyukova A, Brown S, Papa R, OBrien R, Giles J, Trahair T, et al.
Leukemia
. 2012 Dec;
27(5):1053-62.
PMID: 23228967
Loss of function mutation in FBXW7, an E3 ubiquitin ligase, is associated with good prognosis and early glucocorticoid treatment response in childhood T-cell acute lymphoblastic leukemia (T-ALL) by unknown mechanisms....